Affiliation:
1. Center of Functional Protein Assemblies Technical University of Munich Garching Germany
2. Institute of Physics University of Augsburg Augsburg Germany
Abstract
AbstractSelf‐assembled aggregation of peptides and proteins into regular amyloid fibrils is associated with several neurodegenerative diseases. In case of Alzheimer's disease proteolytic cleavage products of the amyloid precursor protein form pathological amyloid‐beta fibrils in a nucleation and propagation phase. The molecular details and thermodynamic driving forces of amyloid formation are not well understood, but are of high relevance for potential pharmacological interference. We used atomistic binding free energy simulations to calculate the free energy of protofilament propagation by an additional Aβ9–40 peptide binding to the protofilament tip. It requires sampling of relevant conformational transitions which is challenging since the monomeric Aβ9–40 peptide is intrinsically disordered. However, the convergence of umbrella simulations can be enhanced by applying additional restraining potentials on the axial, orientational and conformational degrees of freedom. The improved convergence leads to a much closer agreement with experimental binding free energy data compared to unrestrained umbrella sampling. Moreover, the restraining approach results in a separation of contributions to the total binding free energy. The calculated contributions indicate that the free energy change associated with the restriction of conformational freedom upon propagation makes a large opposing contribution of higher magnitude than the total binding free energy. Finally, optimization of the approach leads to further significant reduction of the computational demand which is crucial for systematic studies on mutations, denaturants and inhibitors in the fibril propagation step.
Funder
Deutsche Forschungsgemeinschaft
Leibniz-Rechenzentrum
Reference48 articles.
1. Protein misfolding, functional amyloid, and human disease;Chiti F;Annu Rev Biochem,2006
2. Amyloid fibril polymorphism: a challenge for molecular imaging and therapy;ndrich M;J Intern Med,2018
3. The expanding amyloid family: structure, stability, function, and pathogenesis;Sawaya MR;Cell,2021
4. Structural studies of amyloid proteins at the molecular level;Eisenberg DS;Annu Rev Biochem,2017
5. A new era for understanding amyloid structures and disease;Iadanza MG;Nat Rev Mol Cell Biol,2018